ADMA - ADMA Biologics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5221.57M
Enterprise Value 3231.01M
Trailing P/E N/A
Forward P/E 1-8.10
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)13.04
Price/Book (mrq)11.19
Enterprise Value/Revenue 313.60
Enterprise Value/EBITDA 6-4.02

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018


Profit Margin 0.00%
Operating Margin (ttm)-354.95%

Management Effectiveness

Return on Assets (ttm)-38.28%
Return on Equity (ttm)-218.77%

Income Statement

Revenue (ttm)16.99M
Revenue Per Share (ttm)0.38
Quarterly Revenue Growth (yoy)-18.90%
Gross Profit (ttm)-25.21M
EBITDA -57.44M
Net Income Avi to Common (ttm)-65.74M
Diluted EPS (ttm)-1.4550
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)22.75M
Total Cash Per Share (mrq)0.49
Total Debt (mrq)41.46M
Total Debt/Equity (mrq)209.73
Current Ratio (mrq)4.63
Book Value Per Share (mrq)0.43

Cash Flow Statement

Operating Cash Flow (ttm)-62.68M
Levered Free Cash Flow (ttm)-39.44M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.48
52-Week Change 3-4.06%
S&P500 52-Week Change 311.15%
52 Week High 36.9600
52 Week Low 32.0800
50-Day Moving Average 34.2977
200-Day Moving Average 34.2678

Share Statistics

Avg Vol (3 month) 31.14M
Avg Vol (10 day) 3836.55k
Shares Outstanding 546.35M
Float 15.08M
% Held by Insiders 125.50%
% Held by Institutions 157.51%
Shares Short (Mar 29, 2019) 43.15M
Short Ratio (Mar 29, 2019) 45.38
Short % of Float (Mar 29, 2019) 415.60%
Short % of Shares Outstanding (Mar 29, 2019) 46.79%
Shares Short (prior month Feb 28, 2019) 42.42M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A